104 related articles for article (PubMed ID: 2988230)
41. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
Ritchie MH; Oakes JE; Lausch RN
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
[TBL] [Abstract][Full Text] [Related]
42. Assay of type-specific and type-common antibodies to herpes simplex virus types 1 and 2 in human sera.
Eberle R; Courtney RJ
Infect Immun; 1981 Mar; 31(3):1062-70. PubMed ID: 6262247
[TBL] [Abstract][Full Text] [Related]
43. ELISA for herpes simplex virus (HSV) type-specific antibodies in human sera using HSV type 1 and type 2 polyspecific antigens blocked with type-heterologous rabbit antibodies.
Vestergaard BF; Grauballe PC
Acta Pathol Microbiol Scand B; 1979 Aug; 87(4):261-3. PubMed ID: 227226
[TBL] [Abstract][Full Text] [Related]
44. Genomic sequences homologous to the protein kinase region of the bifunctional herpes simplex virus type 2 protein ICP10.
Smith CC; Wymer JP; Luo J; Aurelian L
Virus Genes; 1991 Jul; 5(3):215-26. PubMed ID: 1663292
[TBL] [Abstract][Full Text] [Related]
45. Crossed immunoelectrophoretic studies of the solubility immunogenicity of herpes simplex virus antigens.
Vestergaard BF; Bjerrum OJ; Norrild B; Grauballe PC
J Virol; 1977 Oct; 24(1):82-90. PubMed ID: 198588
[TBL] [Abstract][Full Text] [Related]
46. Is ribonucleotide reductase the transforming function of herpes simplex virus 2?
Huszar D; Bacchetti S
Nature; 1983 Mar; 302(5903):76-9. PubMed ID: 6298637
[TBL] [Abstract][Full Text] [Related]
47. Complement-mediated cytolysis of HSV-1 and HSV-2 infected cells: plasma membrane antigens reactive with type-specific and cross-reactive antibody.
Glorioso JC; Wilson LA; Fenger TW; Smith JW
J Gen Virol; 1978 Aug; 40(2):443-54. PubMed ID: 211189
[TBL] [Abstract][Full Text] [Related]
48. Monoclonal antibodies against herpes simplex viruses.
Scheffer AJ; Koedijk DG; Abee T; Osterhaus AD
Dev Biol Stand; 1984; 57():269-74. PubMed ID: 6098497
[TBL] [Abstract][Full Text] [Related]
49. A solid-phase assay for the binding of peptidic subunit association inhibitors to the herpes simplex virus ribonucleotide reductase large subunit.
Krogsrud RL; Welchner E; Scouten E; Liuzzi M
Anal Biochem; 1993 Sep; 213(2):386-94. PubMed ID: 8238915
[TBL] [Abstract][Full Text] [Related]
50. Class-specific antibody responses to early and late antigens of varicella and herpes simplex viruses.
Schmidt NJ; Gallo D
J Med Virol; 1984; 13(1):1-12. PubMed ID: 6319583
[TBL] [Abstract][Full Text] [Related]
51. Protective immunization of mice with specific HSV-1 glycoproteins.
Chan WL
Immunology; 1983 Jun; 49(2):343-52. PubMed ID: 6303950
[TBL] [Abstract][Full Text] [Related]
52. Neutralization of herpes simplex virus ribonucleotide reductase activity by an oligopeptide-induced antiserum directed against subunit H2.
Cohen EA; Gaudreau P; Brazeau P; Langelier Y
J Virol; 1986 Dec; 60(3):1130-3. PubMed ID: 2431161
[TBL] [Abstract][Full Text] [Related]
53. Immune interactions with cells infected with herpes simplex virus: antibodies to radioiodinated surface antigens.
Glorioso JC; Smith JW
J Immunol; 1977 Jan; 118(1):114-21. PubMed ID: 187696
[TBL] [Abstract][Full Text] [Related]
54. The ribonucleotide reductase R1 subunits of herpes simplex virus types 1 and 2 protect cells against TNFα- and FasL-induced apoptosis by interacting with caspase-8.
Dufour F; Sasseville AM; Chabaud S; Massie B; Siegel RM; Langelier Y
Apoptosis; 2011 Mar; 16(3):256-71. PubMed ID: 21107701
[TBL] [Abstract][Full Text] [Related]
55. Characterization of the tumor-associated 38-kd protein of herpes simplex virus type 2.
Trimble JJ; Gay H; Docherty JJ
J Reprod Med; 1986 May; 31(5 Suppl):399-409. PubMed ID: 3014138
[TBL] [Abstract][Full Text] [Related]
56. Immunoblotting and ELISA analysis of HSV-1 and HSV-2-specified polypeptides by using an immunoblocking method.
Lehtinen M
Ann Clin Res; 1985; 17(2):66-70. PubMed ID: 2412480
[TBL] [Abstract][Full Text] [Related]
57. Stress up-regulates neuronal expression of the herpes simplex virus type 2 large subunit of ribonucleotide reductase (R1; ICP10) by activating activator protein 1.
Gober MD; Wales SQ; Hunter JC; Sharma BK; Aurelian L
J Neurovirol; 2005 Aug; 11(4):329-36. PubMed ID: 16162476
[TBL] [Abstract][Full Text] [Related]
58. The protein kinase activity of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) fused to the extracellular domain of the epidermal growth factor receptor is ligand-inducible.
Smith CC; Luo JH; Aurelian L
Virology; 1996 Mar; 217(2):425-34. PubMed ID: 8610433
[TBL] [Abstract][Full Text] [Related]
59. Typing of herpes simplex virus types 1 and 2 by immunoblotting analysis using polyclonal antisera to herpes simplex virus glycoproteins.
Okazaki K; Chiya S; Ideguchi S; Kimura S
J Virol Methods; 1987 Nov; 18(2-3):169-78. PubMed ID: 2828400
[TBL] [Abstract][Full Text] [Related]
60. A cultured human oligodendroglioma cell line and herpes simplex virus-infected cells share antigenic determinants.
Kennedy PG; Watkins BA; LaThangue NB; Clements GB; Thomas DG
J Neurooncol; 1987; 4(4):389-96. PubMed ID: 2437255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
